-
Viridian Therapeutics (NASDAQ:VRDN) Receives "Buy" Rating from Needham & Company LLC
ソース: Buzz FX / 25 11 2024 08:21:10 America/New_York
Viridian Therapeutics (NASDAQ:VRDN) Receives "Buy" Rating from Needham & Company LLC Written by MarketBeat November 25, 2024 Share Link copied to clipboard. Viridian Therapeutics ( NASDAQ:VRDN - Get Free Report ) 's stock had its "buy" rati
Read more...